CTX-471

N/A

Report date: 2026/05/15 20:01:45

Base Information

Drug NameCTX-471
Drug Alias NameCTX-471
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionTumor necrosis factor receptor superfamily member 9 agonistsAntibody-dependent cell-mediated cytotoxicity (ADCC) effects
TargetsTumor necrosis factor receptor superfamily member 9
Therapy Area/IndicationsSolid tumoursNeoplasm MetastasisSmall Cell Lung Carcinoma +[9] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesCompass Therapeutics LLC
China Registration ClassN/A

Develop Information

Active CompaniesCompass Therapeutics LLCCompass Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursNeoplasm MetastasisSmall Cell Lung Carcinoma +[9] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A